ReviewOptimal management of metastatic castration-resistant prostate cancer: Highlights from a European Expert Consensus Panel
Under a Creative Commons license
open access
Keywords
Metastatic castration-resistant prostate cancer
Consensus
Radium 223 dichloride
Abiraterone
Enzalutamide
Docetaxel
Circulating tumour cells
Sipuleucel-T
Cabazitaxel
Denosumab
Cited by (0)
Financial support was provided by an educational grant from Sanofi Oncology.
Copyright © 2014 The Authors. Published by Elsevier Ltd.